vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and Bio-Techne (TECH). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $295.9M, roughly 1.4× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -15.5%, a 28.4% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -11.6%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
EPC vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $295.9M |
| Net Profit | $-65.7M | $38.0M |
| Gross Margin | 38.1% | 64.6% |
| Operating Margin | -4.5% | 18.4% |
| Net Margin | -15.5% | 12.8% |
| Revenue YoY | -11.6% | -6.4% |
| Net Profit YoY | -3028.6% | 68.3% |
| EPS (diluted) | $-1.41 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $295.9M | ||
| Q3 25 | $600.5M | — | ||
| Q2 25 | $627.2M | $317.0M | ||
| Q1 25 | $580.7M | $316.2M | ||
| Q4 24 | $415.1M | $297.0M | ||
| Q3 24 | $517.6M | $289.5M | ||
| Q2 24 | $647.8M | $306.1M | ||
| Q1 24 | $599.4M | $303.4M |
| Q4 25 | $-65.7M | $38.0M | ||
| Q3 25 | $-30.6M | — | ||
| Q2 25 | $29.1M | $-17.7M | ||
| Q1 25 | $29.0M | $22.6M | ||
| Q4 24 | $-2.1M | $34.9M | ||
| Q3 24 | $8.8M | $33.6M | ||
| Q2 24 | $49.0M | $40.6M | ||
| Q1 24 | $36.0M | $49.1M |
| Q4 25 | 38.1% | 64.6% | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 42.8% | 62.7% | ||
| Q1 25 | 44.1% | 67.9% | ||
| Q4 24 | 41.6% | 65.3% | ||
| Q3 24 | 41.1% | 63.2% | ||
| Q2 24 | 44.3% | 66.4% | ||
| Q1 24 | 43.1% | 67.4% |
| Q4 25 | -4.5% | 18.4% | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | 8.6% | -7.5% | ||
| Q1 25 | 10.1% | 12.2% | ||
| Q4 24 | 2.2% | 16.0% | ||
| Q3 24 | 3.9% | 13.8% | ||
| Q2 24 | 12.8% | 15.0% | ||
| Q1 24 | 11.7% | 22.1% |
| Q4 25 | -15.5% | 12.8% | ||
| Q3 25 | -5.1% | — | ||
| Q2 25 | 4.6% | -5.6% | ||
| Q1 25 | 5.0% | 7.1% | ||
| Q4 24 | -0.5% | 11.7% | ||
| Q3 24 | 1.7% | 11.6% | ||
| Q2 24 | 7.6% | 13.3% | ||
| Q1 24 | 6.0% | 16.2% |
| Q4 25 | $-1.41 | $0.24 | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.62 | $-0.11 | ||
| Q1 25 | $0.60 | $0.14 | ||
| Q4 24 | $-0.04 | $0.22 | ||
| Q3 24 | $0.18 | $0.21 | ||
| Q2 24 | $0.98 | $0.26 | ||
| Q1 24 | $0.72 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $172.9M |
| Total DebtLower is stronger | $1.5B | $260.0M |
| Stockholders' EquityBook value | $1.5B | $2.0B |
| Total Assets | $3.8B | $2.5B |
| Debt / EquityLower = less leverage | 1.03× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | $209.1M | $187.5M | ||
| Q2 24 | — | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | $1.5B | $260.0M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $346.0M | ||
| Q1 25 | $1.4B | $330.0M | ||
| Q4 24 | $1.4B | $300.0M | ||
| Q3 24 | $1.3B | $300.0M | ||
| Q2 24 | $1.3B | $319.0M | ||
| Q1 24 | $1.4B | $389.0M |
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | $1.9B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.5B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.6B | $2.1B | ||
| Q1 24 | $1.6B | $2.0B |
| Q4 25 | $3.8B | $2.5B | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.8B | $2.6B | ||
| Q1 25 | $3.8B | $2.6B | ||
| Q4 24 | $3.7B | $2.7B | ||
| Q3 24 | $3.7B | $2.7B | ||
| Q2 24 | $3.7B | $2.7B | ||
| Q1 24 | $3.8B | $2.7B |
| Q4 25 | 1.03× | 0.13× | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | 0.18× | ||
| Q1 25 | 0.95× | 0.16× | ||
| Q4 24 | 0.97× | 0.14× | ||
| Q3 24 | 0.81× | 0.14× | ||
| Q2 24 | 0.82× | 0.15× | ||
| Q1 24 | 0.88× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | — |
| Free Cash FlowOCF − Capex | $-137.5M | — |
| FCF MarginFCF / Revenue | -32.5% | — |
| Capex IntensityCapex / Revenue | 2.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | — | ||
| Q3 25 | $74.1M | — | ||
| Q2 25 | $114.8M | $98.2M | ||
| Q1 25 | $45.1M | $41.1M | ||
| Q4 24 | $-115.6M | $84.3M | ||
| Q3 24 | $-388.3M | $63.9M | ||
| Q2 24 | $101.2M | $75.5M | ||
| Q1 24 | $129.0M | $81.0M |
| Q4 25 | $-137.5M | — | ||
| Q3 25 | $46.5M | — | ||
| Q2 25 | $99.3M | $93.3M | ||
| Q1 25 | $28.0M | $31.0M | ||
| Q4 24 | $-132.4M | $77.5M | ||
| Q3 24 | $-414.2M | $54.7M | ||
| Q2 24 | $88.6M | $57.5M | ||
| Q1 24 | $117.5M | $64.5M |
| Q4 25 | -32.5% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 15.8% | 29.4% | ||
| Q1 25 | 4.8% | 9.8% | ||
| Q4 24 | -31.9% | 26.1% | ||
| Q3 24 | -80.0% | 18.9% | ||
| Q2 24 | 13.7% | 18.8% | ||
| Q1 24 | 19.6% | 21.3% |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.5% | 1.5% | ||
| Q1 25 | 2.9% | 3.2% | ||
| Q4 24 | 4.0% | 2.3% | ||
| Q3 24 | 5.0% | 3.2% | ||
| Q2 24 | 1.9% | 5.9% | ||
| Q1 24 | 1.9% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.95× | — | ||
| Q1 25 | 1.56× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | -44.13× | 1.90× | ||
| Q2 24 | 2.07× | 1.86× | ||
| Q1 24 | 3.58× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
